StemSight

BiotechnologySeedTampere, Finlandstemsight.fi

Latest round

Seed

Last raised

Sep 2021

Total raised

$0.6M

Investors

2

About StemSight

StemSight Oy, founded in 2021 and headquartered in Tampere, Finland, focuses on developing stem cell-based therapies for corneal blindness. The company was co-founded by Heli Skottman and Laura Koivusalo, the latter of whom also serves as CEO.StemSight specializes in off-the-shelf cell therapies aimed at addressing corneal blindness through innovative applications of induced pluripotent stem (iPS) cells combined with functional biomaterials. Their core product offerings focus on developing biocompatible corneal tissues, particularly through their involvement in the EU-funded KeratOPrinter project, which utilizes advanced bioprinting technology to create full-thickness corneas.2. The company is also targeting expansion into new European markets to increase its reach and impact in treating corneal blindness.

Who invested in StemSight

2 investors across 1 round

See all investors in StemSight

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Seed

    Sep 13, 2021

    Amount

    $0.6M

    Investors

    Locked

Questions about StemSight

Who invested in StemSight?

StemSight has 2 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has StemSight raised?

StemSight has raised 1 venture round. Sign up free to see how much each round raised and the total.

When did StemSight last raise money?

StemSight's most recent round on record is a Seed, in Sep 2021.

What does StemSight do?

StemSight Oy, founded in 2021 and headquartered in Tampere, Finland, focuses on developing stem cell-based therapies for corneal blindness.

Where is StemSight headquartered?

StemSight is headquartered in Tampere, Finland.

Which VCs invest in companies like StemSight?

Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Balderton Capital back biotechnology companies at StemSight's stage. Their profiles are linked below.

Raising like StemSight? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.